Functional Tricuspid Regurgitation Clinical Trial
Official title:
Outcome of MC3 Ring Annuloplasty for Moderate and Severe Functional Tricuspid Regurgitation Associated With Rheumatic Mitral Valve Disease
This study includes 105 patients who underwent repair for ≥ moderate tricuspid regurgitation (TR) during mitral valve replacement for rheumatic valve disease. Between January 2016 and December 2018, a group of 23 patients underwent ring annuloplasty with Edward MC3 rings were compared to another group of 82 patients underwent standard suture (DeVega) repair. The primary outcome was residual TR (≥ moderate TR).
This study evaluated early and midterm outcomes after operations for TV repair which were
performed at our institution, between January 2016 and December 2018. The mean follow-up
duration was 18.84±9.90 months (range: 3-33 months). The study included 105 patients who
underwent repair for FTR during mitral valve replacement for rheumatic valve disease. There
were 82 patients underwent suture (DeVega) repair and 23 patients underwent ring annuloplasty
using Edward MC3 incomplete 3D ring. The indications of surgery for FTR were: (1) severe TR;
or (2) moderate TR with annular dilatation greater than 40 mm and/or preoperative systolic
pulmonary artery pressure (SPAP) >50 mmHg. We excluded patients with non-rheumatic mitral
disease, combined mitral and aortic valve replacement, mitral valve repair, concomitant
coronary artery or aortic surgery, mild or organic tricuspid regurgitation, emergency
surgery, reoperations or missed data. Based on echocardiographic data, the severity of TR was
graded as: 0 (no TR), 1+ (mild TR), 2+ (mild to moderate TR), 3+ (moderately severe TR), or
4+ (severe).
The type of tricuspid valve repair was chosen in according to surgeon's preference and
echocardiographic criteria of TV. The DeVega repair was performed when the patient had
minimal annular dilation and lower severity of pulmonary hypertension, while ring
annuloplasty was performed in patients with severe tricuspid annular dilation and severe
pulmonary hypertension. The DeVega repair was performed on a beating heart using
pledget-supported two 4-0 polypropylene running parallel sutures. The MC3 ring annuloplasty
was performed through right atriotomy using cardiopulmonary bypass and cardioplegic arrest.
The ring size was determined after measurement of the length of the attachments of the
tricuspid septal leaflet (the distance between the anteroseptal and septoposterior
commissures) or the surface area of the anterior leaflet. The chosen ring was undersized by
at least one size. The ring was implanted from the anteroseptal commissure to the middle of
the septal leaflet. A series of 8 to10 mattress sutures with a 2-0 Ethibond multifilament
suture were made on the tricuspid annulus starting from the center of the septal annulus to
the anteroseptal commissure in the counter-clockwise direction, to avoid the atrioventricular
conduction tissue. Thereafter, the sutures were placed through the sewing ring of the
prosthesis , followed by lowering and securing of the ring to the annulus The collected
pre-operative data included age, sex, New York Heart Association (NYHA) functional class, ,
and the type of preoperative mitral valve disease. The primarily assessed post-operative
outcome was residual TR (≥ moderate TR; ≥ grade +2). Other assessed pre- and post-operative
parameters included NYHA functional class, and echocardiographic data regarding grade of TR,
SPAP, tricuspid annulus (TA) diameter, tricuspid annular plane systolic excursion (TAPSE),
left atrial diameter (LAD), left ventricular end-diastolic dimension (LVEDD), left
ventricular end-systolic dimension (LVESD), and left ventricular ejection fraction (LVEF).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03632967 -
Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System
|
N/A | |
Recruiting |
NCT02721524 -
Ring Versus Suture Annuloplasty For Functional Tricuspid Regurgitation In Rheumatic Mitral Valve Diseases
|
N/A | |
Recruiting |
NCT05209919 -
Echocardiographic Assessment and CLInical imPlication of Functional tricuSpid rEgurgitation in Heart Failure With Reduced or Preserved Ejection Fraction
|
||
Completed |
NCT05854095 -
The Study for Evaluation of Acute Phase Safety and Efficacy of 'Pivot Bridge' to Short-term Treat FTR
|
N/A | |
Recruiting |
NCT04141683 -
Right VEntricular Contractile ReSERVE in Functional Tricuspid Regurgitation
|
||
Completed |
NCT05648838 -
Evaluation of Safety and Efficacy of Pivot Balloon to Monitoring Acute RV Failure and Reduction of FTR
|
N/A | |
Recruiting |
NCT04173091 -
Risk Stratification in Severe Treatment-naive, Tricuspid Regurgitation
|
||
Completed |
NCT05836415 -
Effectiveness and Durability Long-term Results of Tricuspid Annuloplasty With 3D Shaped Rings.
|
||
Recruiting |
NCT05920824 -
Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation
|